Boston Trust Walden’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.2M | Buy |
|
|||||
|
2025
Q1 | $30.9M | Buy |
|
|||||
|
2024
Q4 | $37.7M | Buy |
|
|||||
|
2024
Q3 | $38.6M | Sell |
|
|||||
|
2024
Q2 | $41.4M | Buy |
|
|||||
|
2024
Q1 | $52.8M | Sell |
|
|||||
|
2023
Q4 | $46.7M | Buy |
|
|||||
|
2023
Q3 | $37.4M | Buy |
|
|||||
|
2023
Q2 | $40M | Buy |
|
|||||
|
2023
Q1 | $35.2M | Buy |
|
|||||
|
2022
Q4 | $30.6M | Buy |
|
|||||
|
2022
Q3 | $19.7M | Sell |
|
|||||
|
2022
Q2 | $21.6M | Buy |
|
|||||
|
2022
Q1 | $28.1M | Buy |
|
|||||
|
2021
Q4 | $31.8M | Buy |
|
|||||
|
2021
Q3 | $34.5M | Sell |
|
|||||
|
2021
Q2 | $31.7M | Buy |
|
|||||
|
2021
Q1 | $22M | Buy |
|
|||||
|
2020
Q4 | $16.2M | Buy |
|
|||||
|
2020
Q3 | $14.3M | Buy |
|
|||||
|
2020
Q2 | $10.8M | Sell |
|
|||||
|
2020
Q1 | $13.2M | Sell |
|
|||||
|
2019
Q4 | $22.4M | Buy |
|
|||||
|
2019
Q3 | $19.2M | Buy |
|
|||||
|
2019
Q2 | $20.3M | Sell |
|
|||||
|
2019
Q1 | $21M | Buy |
|
|||||
|
2018
Q4 | $16.1M | Sell |
|
|||||
|
2018
Q3 | $20.1M | Sell |
|
|||||
|
2018
Q2 | $17.4M | Buy |
|
|||||
|
2018
Q1 | $12.2M | Sell |
|
|||||
|
2017
Q4 | $13.4M | Buy |
|